(Total Views: 66)
Posted On: 09/14/2023 10:11:01 AM
Post# of 107985

$AVXL News Article - Anavex's Phase 2b/3 Trial of Blarcamesine (ANAVEX 2-73) in Patients with Alzheimer's Disease Shows Robust Clinical Efficacy and Slows Neurodegeneration https://marketwirenews.com/news-releases/anav...55488.html


My Twitter: WhyteStocks